Health Canada has recently authorized Humalog (insulin lispro) 200 units/mL KwikPen. Humalog (insulin lispro) 200 units/mL solution for injection should ONLY be administered using the Humalog 200 units/mL KwikPen in which it is supplied. Transfer of the higher concentration insulin lispro 200 units/mL from the Humalog 200 units/mL KwikPen to a different insulin delivery system may lead to overdose and severe low blood sugar. When switching between one concentration of Humalog KwikPen and the other, it is important to understand that the same number of units of insulin should be chosen for both devices. The Kwikpen automatically delivers the correct volume of insulin so conversion of dose between devices is not needed. Dose conversions, which are unnecessary given the device design, will lead to under or over dosing, resulting in severe low or high blood sugar.
RecallTracker